197 related articles for article (PubMed ID: 30151962)
1. Senescence markers: Predictive for response to checkpoint inhibitors.
Moreira A; Gross S; Kirchberger MC; Erdmann M; Schuler G; Heinzerling L
Int J Cancer; 2019 Mar; 144(5):1147-1150. PubMed ID: 30151962
[TBL] [Abstract][Full Text] [Related]
2. Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4
Tanaskovic S; Price P; French MA; Fernandez S
AIDS Res Hum Retroviruses; 2017 Feb; 33(2):101-109. PubMed ID: 27701900
[TBL] [Abstract][Full Text] [Related]
3. Methods for Characterization of Senescent Circulating and Tumor-Infiltrating T-Cells: An Overview from Multicolor Flow Cytometry to Single-Cell RNA Sequencing.
Franzin R; Stasi A; Castellano G; Gesualdo L
Methods Mol Biol; 2021; 2325():79-95. PubMed ID: 34053052
[TBL] [Abstract][Full Text] [Related]
4. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
[TBL] [Abstract][Full Text] [Related]
5. Arterial Stiffness Is Associated With Cytomegalovirus-Specific Senescent CD8
Yu HT; Youn JC; Kim JH; Seong YJ; Park SH; Kim HC; Lee WW; Park S; Shin EC
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28847915
[TBL] [Abstract][Full Text] [Related]
6. Is Chronic Exposure to Low-Dose Organochlorine Pesticides a New Risk Factor of T-cell Immunosenescence?
Ryu DH; Yu HT; Kim SA; Lee YM; Hong SH; Yoon YR; Kim DJ; Kim HC; Moon HB; Shin EC; Lee DH
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1159-1167. PubMed ID: 29991517
[No Abstract] [Full Text] [Related]
7. T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Subhi Y; Nielsen MK; Molbech CR; Oishi A; Singh A; Nissen MH; Sørensen TL
Aging (Albany NY); 2017 Nov; 9(11):2436-2452. PubMed ID: 29165313
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.
Suen H; Brown R; Yang S; Weatherburn C; Ho PJ; Woodland N; Nassif N; Barbaro P; Bryant C; Hart D; Gibson J; Joshua D
Leukemia; 2016 Aug; 30(8):1716-24. PubMed ID: 27102208
[TBL] [Abstract][Full Text] [Related]
9. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
10. Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment.
Gorris MAJ; Halilovic A; Rabold K; van Duffelen A; Wickramasinghe IN; Verweij D; Wortel IMN; Textor JC; de Vries IJM; Figdor CG
J Immunol; 2018 Jan; 200(1):347-354. PubMed ID: 29141863
[TBL] [Abstract][Full Text] [Related]
11. Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypes.
Onyema OO; Njemini R; Forti LN; Bautmans I; Aerts JL; De Waele M; Mets T
Arch Gerontol Geriatr; 2015; 61(3):494-502. PubMed ID: 26277688
[TBL] [Abstract][Full Text] [Related]
12. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
Zelle-Rieser C; Thangavadivel S; Biedermann R; Brunner A; Stoitzner P; Willenbacher E; Greil R; Jöhrer K
J Hematol Oncol; 2016 Nov; 9(1):116. PubMed ID: 27809856
[TBL] [Abstract][Full Text] [Related]
13. Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs: an observational case-control study.
Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T
BMC Cancer; 2015 Dec; 15():1016. PubMed ID: 26711627
[TBL] [Abstract][Full Text] [Related]
14. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency of late-senescent T cells lacking CD127 in chronic hepatitis C disease.
Barathan M; Mohamed R; Saeidi A; Vadivelu J; Chang LY; Gopal K; Ram MR; Ansari AW; Kamarulzaman A; Velu V; Larsson M; Shankar EM
Eur J Clin Invest; 2015 May; 45(5):466-74. PubMed ID: 25721991
[TBL] [Abstract][Full Text] [Related]
16. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
[TBL] [Abstract][Full Text] [Related]
17. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Chen PL; Roh W; Reuben A; Cooper ZA; Spencer CN; Prieto PA; Miller JP; Bassett RL; Gopalakrishnan V; Wani K; De Macedo MP; Austin-Breneman JL; Jiang H; Chang Q; Reddy SM; Chen WS; Tetzlaff MT; Broaddus RJ; Davies MA; Gershenwald JE; Haydu L; Lazar AJ; Patel SP; Hwu P; Hwu WJ; Diab A; Glitza IC; Woodman SE; Vence LM; Wistuba II; Amaria RN; Kwong LN; Prieto V; Davis RE; Ma W; Overwijk WW; Sharpe AH; Hu J; Futreal PA; Blando J; Sharma P; Allison JP; Chin L; Wargo JA
Cancer Discov; 2016 Aug; 6(8):827-37. PubMed ID: 27301722
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
[TBL] [Abstract][Full Text] [Related]
20. Features of Immunosenescence in Women Newly Diagnosed With Breast Cancer.
Trintinaglia L; Bandinelli LP; Grassi-Oliveira R; Petersen LE; Anzolin M; Correa BL; Schuch JB; Bauer ME
Front Immunol; 2018; 9():1651. PubMed ID: 30061900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
